281 related articles for article (PubMed ID: 22096249)
1. Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia.
Sampath D; Liu C; Vasan K; Sulda M; Puduvalli VK; Wierda WG; Keating MJ
Blood; 2012 Feb; 119(5):1162-72. PubMed ID: 22096249
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
Chen CQ; Chen CS; Chen JJ; Zhou LP; Xu HL; Jin WW; Wu JB; Gao SM
Mol Cell Biochem; 2013 Nov; 383(1-2):137-48. PubMed ID: 23867991
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia.
Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E
Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789
[TBL] [Abstract][Full Text] [Related]
4. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
[TBL] [Abstract][Full Text] [Related]
5. Myc represses miR-15a/miR-16-1 expression through recruitment of HDAC3 in mantle cell and other non-Hodgkin B-cell lymphomas.
Zhang X; Chen X; Lin J; Lwin T; Wright G; Moscinski LC; Dalton WS; Seto E; Wright K; Sotomayor E; Tao J
Oncogene; 2012 Jun; 31(24):3002-3008. PubMed ID: 22002311
[TBL] [Abstract][Full Text] [Related]
6. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.
Lu K; Fang XS; Feng LL; Jiang YJ; Zhou XX; Liu X; Li PP; Chen N; Ding M; Wang N; Zhang J; Wang X
Cancer Lett; 2015 Apr; 359(2):250-8. PubMed ID: 25636517
[TBL] [Abstract][Full Text] [Related]
7. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.
Fabbri M; Bottoni A; Shimizu M; Spizzo R; Nicoloso MS; Rossi S; Barbarotto E; Cimmino A; Adair B; Wojcik SE; Valeri N; Calore F; Sampath D; Fanini F; Vannini I; Musuraca G; Dell'Aquila M; Alder H; Davuluri RV; Rassenti LZ; Negrini M; Nakamura T; Amadori D; Kay NE; Rai KR; Keating MJ; Kipps TJ; Calin GA; Croce CM
JAMA; 2011 Jan; 305(1):59-67. PubMed ID: 21205967
[TBL] [Abstract][Full Text] [Related]
8. ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.
Chiang CL; Goswami S; Frissora FW; Xie Z; Yan PS; Bundschuh R; Walker LA; Huang X; Mani R; Mo XM; Baskar S; Rader C; Phelps MA; Marcucci G; Byrd JC; Lee LJ; Muthusamy N
Blood; 2019 Aug; 134(5):432-444. PubMed ID: 31151986
[TBL] [Abstract][Full Text] [Related]
9. microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia.
Deneberg S; Kanduri M; Ali D; Bengtzen S; Karimi M; Qu Y; Kimby E; Mansouri L; Rosenquist R; Lennartsson A; Lehmann S
Epigenetics; 2014 Jun; 9(6):910-7. PubMed ID: 24686393
[TBL] [Abstract][Full Text] [Related]
10. Targeting BTK through microRNA in chronic lymphocytic leukemia.
Bottoni A; Rizzotto L; Lai TH; Liu C; Smith LL; Mantel R; Reiff S; El-Gamal D; Larkin K; Johnson AJ; Lapalombella R; Lehman A; Plunkett W; Byrd JC; Blachly JS; Woyach JA; Sampath D
Blood; 2016 Dec; 128(26):3101-3112. PubMed ID: 27756747
[TBL] [Abstract][Full Text] [Related]
11. Investigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLL).
Hanlon K; Rudin CE; Harries LW
PLoS One; 2009 Sep; 4(9):e7169. PubMed ID: 19779621
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.
Amodio N; Stamato MA; Gullà AM; Morelli E; Romeo E; Raimondi L; Pitari MR; Ferrandino I; Misso G; Caraglia M; Perrotta I; Neri A; Fulciniti M; Rolfo C; Anderson KC; Munshi NC; Tagliaferri P; Tassone P
Mol Cancer Ther; 2016 Jun; 15(6):1364-75. PubMed ID: 27196750
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
[TBL] [Abstract][Full Text] [Related]
14. Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia.
Veronese A; Pepe F; Chiacchia J; Pagotto S; Lanuti P; Veschi S; Di Marco M; D'Argenio A; Innocenti I; Vannata B; Autore F; Marchisio M; Wernicke D; Verginelli F; Leone G; Rassenti LZ; Kipps TJ; Mariani-Costantini R; Laurenti L; Croce CM; Visone R
Leukemia; 2015 Jan; 29(1):86-95. PubMed ID: 24732594
[TBL] [Abstract][Full Text] [Related]
15. Investigation of 13q14.3 deletion by cytogenetic analysis and FISH technique and miRNA-15a and miRNA-16-1 by real time PCR in chronic lymphocytic leukemia.
Yılmaz M; Kuru RD; Erdoğan I; Soysal T; Hacıhanefioglu S; Baykara O
Afr Health Sci; 2022 Sep; 22(3):173-182. PubMed ID: 36910369
[TBL] [Abstract][Full Text] [Related]
16. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity.
Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES
Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889
[TBL] [Abstract][Full Text] [Related]
17. Aberrant microRNA expression in Chinese patients with chronic lymphocytic leukemia.
Zhu DX; Miao KR; Fang C; Fan L; Zhu W; Zhu HY; Zhuang Y; Hong M; Liu P; Xu W; Li JY
Leuk Res; 2011 Jun; 35(6):730-4. PubMed ID: 21130495
[TBL] [Abstract][Full Text] [Related]
18. Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia.
Mims A; Walker AR; Huang X; Sun J; Wang H; Santhanam R; Dorrance AM; Walker C; Hoellerbauer P; Tarighat SS; Chan KK; Klisovic RB; Perrotti D; Caligiuri MA; Byrd JC; Chen CS; James Lee L; Jacob S; Mrózek K; Bloomfield CD; Blum W; Garzon R; Schwind S; Marcucci G
Leukemia; 2013 Apr; 27(4):871-8. PubMed ID: 23178755
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-15a and miR-16-1 in patients with chronic lymphocytic leukemia.
Humplikova L; Kollinerova S; Papajik T; Pikalova Z; Holzerova M; Prochazka V; Divoka M; Modriansky M; Indrak K; Jarosova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):284-93. PubMed ID: 24026141
[TBL] [Abstract][Full Text] [Related]
20. Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy.
Cutrona G; Matis S; Colombo M; Massucco C; Baio G; Valdora F; Emionite L; Fabris S; Recchia AG; Gentile M; Neumaier CE; Reverberi D; Massara R; Boccardo S; Basso L; Salvi S; Rosa F; Cilli M; Zupo S; Truini M; Tassone P; Calabrese M; Negrini M; Neri A; Morabito F; Fais F; Ferrarini M
Leukemia; 2017 Sep; 31(9):1894-1904. PubMed ID: 28053325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
